Altermune Technologies - Alphamer Technology's Unit Acquisition

Altermune Technologies - Alphamer Technology raised a round of funding on January 18, 2016. Investors include Centauri Therapeutics.

Altermune Technologies develops therapeutics to combat drug-resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza.…

Articles about Altermune Technologies - Alphamer Technology's Unit Acquisition: